Glyconics has signed an exclusive licensing deal with Ghent University in Belgium for its proprietary method for the measurement of Diabetes 

Archangels and Scottish Investment Bank have invested £2 million in Bio-Images Drug Delivery Limited (BDD). 

Hats off to HBAN who funded an angel deal just 48 hours after the pitch.

How did this investment which is possibly the speediest investment ever (let me know if you know of a quicker one) happen?  HBAN explained that it was partly because with previous investors, including HBAN angels, already in the deal, all the due diligence was in place.

Tikehau Capital, the pan-European alternative asset management and investment company, and SPRIM Ventures, a world-class global medical and scientific consultancy firm, has announced the initial closing of their first venture capital fund, TKS1, which will focus on early stage investments in med-tech and life science companies. 

NVM has led a £5 million growth capital minority investment into Manchester-based Currentbody, an online retailer for home-use beauty devices. Having achieved exceptional sales growth in the last year, the investment will help support its next phase of expansion, allowing the company to accelerate its strategic initiatives and support working capital requirements. 

Co-Founded by Laurence Newman and Andrew Showman, CURRENTBODY.com is the only website specialising in beauty devices for home use.

HBAN has invested €50,000 in Incereb, a neonatal monitoring sensors company, just 48 hours after hearing the Irish company’s presentation.

Doctor-on-demand app Qured has closed a joint angel and crowd raise of £1.13m through SeedLegals  and Seedrs, at a post-money valuation  of £5.16m.

Cellesce the cancer organoid bioprocessing and scale-up company has announced a successful six-figure funding round that will open up opportunities to introduce its organoid scale-up and expansion technology to the oncology drug discovery screening market. This funding round has, once again, been led by the Development Bank of Wales, a measure of the confidence it has in both the Cellesce technology and the founding team.

Origin Capital and Qi3 Ventures have realised their joint investment in pet health company Lintbells.
Origin and Qi3 backed Lintbells at an early stage of it’s growth in April 2012.

HBAN (Halo Business Angel Network) has invested €300,000 in Kilkenny-based ND Sports Performance and its cloud-based hamstring assessment system products for hamstring injury prevention and improving athlete performance. The funding, which will lead to the creation of up to 10 new jobs, was led by HBAN’s South East Business Angel Network (SEBAN), with support from Enterprise Ireland.

Draper Esprit has co-led in a $12.3 million fund raising by Evonetix, a Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis.

Zilico, part of the Deepbridge Technology Growth EIS portfolio, has secured investment of £13.7 million in its latest funding  round. 

Deepbridge has contributed £3 million of this, with other backers including MaxHealth Medicine Group.